Download PDF
Cent Eur Neurosurg 2010; 71(4): 181-188
DOI: 10.1055/s-0030-1261947
Original Article

© Georg Thieme Verlag KG Stuttgart · New York

Magnetic Resonance Imaging of Rare Intracranial Neoplasms – Role of the In Vivo 1 H Spectroscopy in the Radiological Differential Diagnostics

J. Fortuniak1 , D. J. Jaskólski1 , L. Stefańczyk2 , M. Zawirski1 , W. Gajewicz2
  • 1Barlicki University Hospital, Neurosurgery, Łódź, Poland
  • 2Medical University of Łódź, Radiology, Łódź, Poland
Further Information

Publication History

Publication Date:
16 November 2010 (online)

    Permissions and Reprints

Abstract

Background: The object of this study was to evaluate the usefulness of magnetic resonance (MR) spectroscopy in differentiating rare intracranial tumours in adult patients. Review of the literature on results of MR spectroscopy in these lesions is also included.

Material and Method: 89 patients with brain tumours were evaluated preoperatively with in vivo 1.5 T MR spectroscopy (according to eTumour study requirments). 8 of them were diagnosed as having very rare neoplasms: haemangiopericytoma (2), lymphoma (2), plexus papilloma (2), chondroma (1) and purkinjoma (1). Spectra of these tumours were compared to spectra of common brain tumours that could resemble these lesions.

Results: MR spectroscopy enabled discrimination between meningiomas and haemangiopericytomas, meningiomas and lymphomas, and purkinjomas or chondromas and other brain tumours. The method was unreliable in distinguishing between glioblastomas and lymphomas.

Conclusion: The small number of patients made statistical analysis impossible. However, at present, it seems that neuroradiological diagnosis should not rely on MR spectroscopy alone.

Key words

magnetic resonance - MR spectroscopy - brain tumours

References

  • 1 Agris PF, Campbell ID. Proton nuclear magnetic resonance of intact Friend leukemia cells:phosphorylcholine increase during differentiation.  Science. 1982;  216 1325-1327
    Google Scholar
  • 2 Barba I, Moreno A, Martinez-Perez I. et al . Magnetic resonance spectroscopy of brain haemangiopericytomas: high myoinositol concentrations and discrimination from meningiomas.  J Neurosurg. 2001;  94 55-60
    Google Scholar
  • 3 Bizzi A, Movsas B, Tedeschi G. et al . Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-1 MR spectroscopic imaging.  Radiology. 1995;  194 (1) 271-276
    Google Scholar
  • 4 Bonneville F, Fabrice J, Savatovsky J. Imaging of cerebellopontine angle lesions: an update. Part 1: enhancing extra-axial lesions.  European Radiology. 2007;  17 (10) 2472-2482
    Google Scholar
  • 5 Bourgouin PM, Tampieri D, Robitaille Y. et al . Low-grade myxoid chondrosarcoma of the base of the skull: CT, MR and histopathology.  J Comput Assist Tomogr. 1992;  16 268-273
    Google Scholar
  • 6 Burger PC, Scheithauer BW. Tumours of the central nervous system. Armed Forces Institute of Pathology: Washington DC; 1994: 136-142
    Google Scholar
  • 7 Calli C, Kitis O, Yunten N. et al . Perfusion and diffusion MR imaging in enhancing malignant cerebral tumours.  Eur J Radiol. 2006;  58 (3) 394-403
    Google Scholar
  • 8 Celda B, Monleón D, Martínez-Bisbal MC. et al . MRS as endogenous molecular imaging for brain and prostate tumours: FP6 project “eTUMOUR”.  Adv Exp Med Biol. 2006;  587 285-302
    Google Scholar
  • 9 Chang KH, Song IC, Kim SH. et al . In vivo single-voxel proton MR spectroscopy in intracranial cystic masses.  AJNR. 1998;  19 401-405
    Google Scholar
  • 10 Chiechi MV, Smirniotopoulos JG, Mena H. Intracranial hemangiopericytomas: MR and CT features.  AJNR. 1996;  17 1365-1371
    Google Scholar
  • 11 Cummings TJ, Bridge JA, Fukushima T. Extraskeletal myxoid chondrosarcoma of the jugular foramen.  Clin Neuropathol. 2004;  23 232-237
    Google Scholar
  • 12 Fountas KN, Kapsalski EZ, Vogel RL. et al . Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy.  Stereotact Funct Neurosurg. 2004;  82 90-97
    Google Scholar
  • 13 Galanis E, Buckner JC, Scheithauer BW. et al . Management of recurrent meningeal hemangiopericytoma.  Cancer. 1998;  82 1915-1920
    Google Scholar
  • 14 García-Gómez JM, Luts J, Julià-Sapé M. et al . Multiproject-multicenter evaluation of automatic brain tumour classification by magnetic resonance spectroscopy.  MAGMA. 2009;  22 (1) 5-18
    Google Scholar
  • 15 Guthrie BL, Ebersold MJ, Scheithauer BW. et al . Meningeal hemangiopericytoma: histopathological features, treatment and long-term follow-up of 44 cases.  Neurosurgery. 1989;  25 514-522
    Google Scholar
  • 16 Harris LM, Davies N, Macpherson L. et al . The use of short-echo-time 1 H MRS for childhood cerebellar tumours prior to histopathological diagnosis.  Pediatr Radiol. 2007;  37 (11) 1101-1109
    Google Scholar
  • 17 Harting I, Hartmann M, Jost G. et al . Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy.  Neurosci Lett. 2003;  342 163-166
    Google Scholar
  • 18 Herminghaus S, Pilatus U, Möller-Hartmann W. et al . Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumours.  NMR Biomed. 2002;  15 385-392
    Google Scholar
  • 19 Holmes KT, Lean CL, Hunt NH. et al . Development of the “activated” high resolution 1H-MR spectrum in murine T cells and B-cells occurs in G1 phase of the cell cycle.  Magn Reson Med. 1990;  16 1-8
    Google Scholar
  • 20 Horska A, Ulig AM, Melhem ER. et al . Proton magnetic resonance spectroscopy of choroid plexus tumours in children.  JMRI. 2001;  14 78-82
    Google Scholar
  • 21 Ishimaru H, Morikawa M, Iwanaga S. et al . Differentiation between high-grade glioma and metastatic brain tumour using single-voxel proton MR spectroscopy.  Eur Radiol. 2001;  11 (9) 1784-1791
    Google Scholar
  • 22 Jaskólski DJ, Papierz W, Biernat W. et al .Nowotwory Osrodkowego Uk–adu Nerwowego [Neoplasms of the Central Nervous System]. In: Kozubski W, Liberski P. (eds) Choroby Uk–adu Nerwowego [Diseases of the Nervous System]. PZWL, Warszawa. 2004
    Google Scholar
  • 23 King NJC, Ward MH, Holmes KT. MR studies of murine macrophages: proliferation is not a prerequisite for activation of an “activated” high resolution spectrum.  FEBS Lett. 1991;  287 97-101
    Google Scholar
  • 24 Kinoshita Y, Yokota A. Absolute concentrations of metabolites in human brain tumours using in vitro proton magnetic resonance spectroscopy.  NMR Biomed. 1997;  10 2-12
    Google Scholar
  • 25 Kleihues P, Cavenee WK. Pathology and Genetics of Tumours of the Nervous System.. IARC Press; 2000
    Google Scholar
  • 26 Klisch J, Juengling F, Spreer J. Lhermitte-Duclos disease: assessment with MR imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy.  AJNR. 2001;  22 (5) 824-830
    Google Scholar
  • 27 Martínez-Bisbal MC, Martí-Bonmatí L, Piquer J. et al . 1 H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1 H MRS study of human high grade gliomas.  NMR Biomed. 2004;  17 (4) 191-205
    Google Scholar
  • 28 Mena H, Ribas JL, Pezeshkpour GH. et al . Hemangiopericytoma of the central nervous system: a review of 94 cases.  Hum Pathol. 1991;  22 84-91
    Google Scholar
  • 29 Meyerand ME, Pipas JM, Mamourian A. et al . Classification of biopsy-confirmed brain tumours using single-voxel MR spectroscopy.  AJNR. 1999;  20 117-123
    Google Scholar
  • 30 Möller-Hartmann W, Herminghaus S, Krings T. et al . Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.  Neuroradiology. 2002;  44 (5) 371-381
    Google Scholar
  • 31 Murray C, Shipman P, Khangure M. et al . Lhermitte-Duclos disease associated with Cowden syndrome: case report and literature review.  Australas Radiol. 2001;  45 343-346
    Google Scholar
  • 32 Nagaraja S, Powell T, Griffiths PD. et al . MR imaging and spectroscopy in Lhermitte-Duclos disease.  Neuroradiology. 2004;  46 355-358
    Google Scholar
  • 33 Nowak DA, Trost HA. Lhermitte-Duclos disease (dysplastic cerebellar gangliocytoma): a malformation, hamartoma or neoplasm?.  Acta Neurol Scand. 2002;  105 137-145
    Google Scholar
  • 34 Nowak DA, Trost HA, Porr A. et al . Lhermitte-Duclos disease (dysplastic gangliocytoma of the cerebellum).  Clin Neurol Neurosurg. 2001;  103 105-110
    Google Scholar
  • 35 Padma MV. Functional imaging in Lhermitte-Duclose disease.  Mol Imaging Biol. 2004;  6 (5) 319-323
    Google Scholar
  • 36 Poptani H, Gupta R, Roy R. et al . Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.  AJNR Am J Neuroradiol. 1995;  16 1593-1603
    Google Scholar
  • 37 Rizzo L, Crasto SG, Moruno PG. et al . Role of diffusion- and perfusion-weighted MR imaging for brain tumour characterisation.  Radiol Med. 2009;  114 (4) 645-659
    Google Scholar
  • 38 Thomas B, Krishnamoorthy T, Radhakrishnan V. et al . Advanced MR imaging in Lhermitte-Duclos disease: moving closer to pathology and pathophysiology.  Neuroradiology. 2007;  49 (9) 733-738
    Google Scholar
  • 39 Toh CH, Castillo M, Wong AM. et al . Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging.  AJNR. 2008;  29 (3) 471-475
    Google Scholar
  • 40 Tzika AA, Vigneron DB, Dunn RS. et al . Intracranial tumours in children: small single-voxel proton MR spectroscopy using short- and long-echo sequences.  Neuroradiology. 1996;  38 254-263
    Google Scholar
  • 41 Verheggen R, Bruhn H, Schroder BU. et al . Lhermitte-Duclos disease: a critical appraisal of different radiologic methods.  Eur J Radiol. 1994;  19 21-24
    Google Scholar
  • 42 Wang Z, Zimmermann RA, Sauter R. Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children.  AJR. 1996;  167 191-199
    Google Scholar

Correspondence

Dr. J. Fortuniak

Barlicki University Hospital

Neurosurgery

Kopcińskiego 22

91-719 Łódź

Poland

Phone: +48/426/776 771

Fax: +48/426/776 781

Email: jfort@esculap.pl